Correlation Engine 2.0
Clear Search sequence regions


  • antibiotics (2)
  • b dna (1)
  • bacteria (4)
  • clorobiocin (1)
  • coumarin (9)
  • coumermycin a1 (1)
  • gram (3)
  • novobiocin (1)
  • subunit (1)
  • Sizes of these terms reflect their relevance to your search.

    Infections caused by Gram-positive and -negative bacteria are one of the foremost causes of morbidity and mortality globally. Antibiotics are the mainstay of therapy for bacterial infections, but the emergence and wide spread of drug-resistant pathogens have already become a huge issue for public healthcare systems. The coumarin moiety, which is ubiquitous in nature, could bind to the B subunit of DNA gyrase in bacteria and inhibit DNA supercoiling by blocking the ATPase activity; hence, coumarin derivatives possess potential antibacterial activity. Several coumarin-containing hybrids such as coumermycin A1, clorobiocin, and novobiocin have already been used in clinical practice for the treatment of various bacterial infections; thus, it is conceivable that hybridization of the coumarin moiety with other antibacterial pharmacophores may provide opportunities for the development of novel antibiotics. This review outlines the advances in coumarin-containing hybrids with antibacterial potential in the recent 5 years and the structure-activity relationships are also discussed. © 2020 Deutsche Pharmazeutische Gesellschaft.

    Citation

    Dongxu Feng, Aihua Zhang, Yuan Yang, Peng Yang. Coumarin-containing hybrids and their antibacterial activities. Archiv der Pharmazie. 2020 Jun;353(6):e1900380

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 32253782

    View Full Text